Form 8-K Lipocine Inc. For: Oct 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Health Canada approves Tlando oral testosterone therapy from Lipocine
October 7, 2026 6:13 AM EDTHealth Canada has approved TLANDO (testosterone undecanoate) capsules for testosterone replacement therapy (TRT) in adult males with hypogonadism, according to a statement from Lipocine Inc. (NASDAQ: LPCN).
The approval was obtained through Verity Pharmaceuticals Inc., Lipocine's licensing partner, which holds exclusive commercial... More



